Loading...
Selective Janus Kinase Inhibition Preserves Interferon-Λ-mediated Antiviral Responses
Inflammatory diseases are frequently treated with Janus kinase (JAK) inhibitors to diminish cytokine signaling. These treatments can lead to inadvertent immune suppression and may increase the risk of viral infection. Tyrosine kinase 2 (TYK2) is a JAK family member required for efficient type I inte...
Na minha lista:
| Udgivet i: | Sci Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7610871/ https://ncbi.nlm.nih.gov/pubmed/33990378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.abd5318 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|